Aleglitazar is a dual agonist that acts on both PPAR-alpha and PPAR-gamma receptors, functioning as a therapeutic agent within the thiazolidinedione and fibrate classes to manage type 2 diabetes mellitus… Read more
Aleglitazar is a dual agonist that acts on both PPAR-alpha and PPAR-gamma receptors, functioning as a therapeutic agent within the thiazolidinedione and fibrate classes to manage type 2 diabetes mellitus and dyslipidemia. To ensure the integrity of pharmaceutical research and development, analytical laboratories rely on high-quality reference standards, metabolites, and stable isotope labelled compounds related to this drug. These materials are essential for impurity profiling, method validation, and rigorous quality control protocols, allowing researchers to accurately detect and quantify impurities during stability testing. By utilizing these precise analytical tools, chemists can confirm the identity and purity of the drug substance and its degradants throughout the manufacturing process, supporting regulatory compliance and the maintenance of safety standards in pharmaceutical analysis.